Tisch MS News

Feature in The New Scientist

Stem cell therapy reduces symptoms of progressive MS for some people After experimental stem cell therapy, people who required assistance walking due to symptoms of progressive multiple sclerosis saw their mobility improve By Grace Wade 19 May 2023 An experimental stem cell therapy may reduce some...

June 16, 2023

More

Phase II Results

We are very excited to share that the highly-anticipated Phase II results of our FDA-approved stem cell treatment study have been released. Building off the groundbreaking findings in Phase I, this is the first study to show a broad array of regenerative improvements, and have very exciting...

June 13, 2023

More

Summer Fridays

In appreciation of our staff's hard work throughout the year, Tisch MSRCNY will be closing at 2:15 PM on Fridays from now until Labor Day weekend.

June 1, 2023

More

Memorial Day

In observance of Memorial Day, Tisch MSRCNY will be closing on 5/26/23 at 1:00PM and will reopen on 5/30/23 at 9:00AM

May 25, 2023

More

ALL Senior Research Assistants into Medical Schools

We are SO proud of all 6 of our senior research assistants for all of their incredible work at Tisch MSRCNY! This amazing group of RA's are starting their next chapters at Albert Einstein College of Medicine, SUNY Downstate College of Medicine, Tufts University, Boston University's Chobanian and...

May 23, 2023

More

Most Read Article on Biology Open!

We are proud to share the news that Dr. Daviaud's recently published cerebral organoid research has been noted the MOST READ ARTICLE on Biology Open!

April 27, 2023

More

FDA-Approved Phase II Stem Cell Treatment Trial Results Presented at AAN

FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients The study, from the Tisch MS Research Center of New York, is the first to link stem cells with a broad array of improvements in multiple areas Progressive MS patients...

April 25, 2023

More

Tisch MSRCNY Featured in Neuro Rehab Times!

" A study from the Tisch MS Research Center of New York suggests that microglia could be a potential target for mesenchymal stem cell-derived neural progenitor cell (MSC-NP) therapy." Click here to read the full article.

April 24, 2023

More

2023 Patient Education Symposium Recap!

2023 Patient Education Symposium: Where we were, Where we are & Where we are going. The 23rd Annual Tisch MS Research Center of New York Patient Education Symposium took place at the New York Hilton Midtown on March 19th, 2023. Hundreds of attendees gathered to learn about the groundbreaking...

April 19, 2023

More

Tisch MSRCNY Featured in Neuro Rehab Times

We are excited to see Dr. Daviaud's cerebral organoid research featured in an article with Neuro Rehab Times! full story here

April 12, 2023

More

Pages

News Archive

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.